Navigation Links
Clues to Cancer That Could Wipe Out Tasmanian Devils
Date:12/31/2009

Researchers are working on genetic puzzle to try to save the mammals

THURSDAY, Dec. 31 (HealthDay News) -- Researchers are gaining a better understanding of an outbreak of cancerous tumors that is killing many of Australia's Tasmanian devils, according to a new report.

Devil facial tumor disease, a kind of cancer that's spread from animal to animal through biting or other physical contact, is one of only two types of cancer known to be transmitted in this way through living cancer cells (the other such cancer is in dogs). The disease, which quickly kills the animals, starts out as large tumors on the face and mouth, but then can spread to the animals' internal organs.

Advocates fear that the aggressive tumors could kill off Tasmanian devils within a few decades because there currently is no treatment or vaccine.

"Our findings represent a big step forward in the race to save the devils from extinction," study lead author Elizabeth Murchison, of Cold Spring Harbor Laboratory and the Australian National University, said in a news release from the lab.

The researchers report that they've discovered the genetic basis of the cancer, which appears to be linked to a type of tissue that protects nerve cells.

"Now that we've taken a good look at the tumors' genetic profile, we can start hunting for genes and pathways involved in tumor formation," study co-author Greg Hannon, also of Cold Spring Harbor Laboratory, stated in the news release.

The findings are published in the Jan. 1 issue of the journal Science.

More information

The San Diego Zoo has facts about Tasmanian devils.



-- Randy Dotinga



SOURCE: Cold Spring Harbor Laboratory, news release, Dec. 31, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Twins Provide Clues to Lupus
2. Researchers find clues to why some continue to eat when full
3. Smell of old books offers clues to help preserve them
4. Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
5. Research Yields Clues to Severe Form of Sinusitis
6. Facial Structure May Hold Clues to Aggression
7. Gene Discovery Gives Clues to Crohns Disease, Colitis
8. New Clues to How Fish Oils Help Arthritis Patients
9. Clues to visual variant Alzheimers; myopia and diabetic retinopathy risk
10. Clues to Hypertension in Kids May Be Seen in Bones
11. Brain Yields Up Clues to Language
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: